Trial intelligence / Profile preview

Magnesium sulfate vs ondansetron for prevention of shivering during spinal anesthesia

IRCT20171228038117N4Phase 3Completed

Sponsor
Semnan University of Medical Sciences
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in postanesthetic shivering (PAS) comparing Magnesium sulfate with Ondansetron (2 arms). Primary endpoint: Incidence of shivering during and after spinal anesthesia. Started May 2020; status: completed.

02

Drugs

magnesium sulfateondansetron
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20171228038117N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171228038117N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call